Healthcare Global Enterprises Ltd (HCG) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002586, "name": "Health.Global", "stock_name": "Health.Global", "full_name": "Healthcare Global Enterprises Ltd", "name_url": "stocks-analysis/healthglobal", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "567.10", "chg": -0.45, "chgp": "-0.08%", "dir": -1, "prev_price": "567.55", "mcapval": "7,996.54 Cr", "mcap": "Small Cap", "scripcode": 539787, "symbol": "HCG", "ind_name": "Hospital", "ind_code": 94, "indexname": "", "isin": "INE075I01017", "curr_date": "Feb 09", "curr_time": "", "bse_nse_vol": "3.94 lacs", "exc_status": "Active", "traded_date": "Feb 09, 2026", "traded_date_str": "2026 02 09", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/healthglobal-1002586-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Healthcare Global Enterprises Ltd Upgraded to Hold on Mixed Financial and Quality Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-ltd-upgraded-to-hold-on-mixed-financial-and-quality-signals-3828050", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_mojoScore_3828050.png", "date": "2026-02-09 08:19:48", "description": "Healthcare Global Enterprises Ltd has seen its investment rating upgraded from Sell to Hold as of 6 February 2026, reflecting a nuanced reassessment of its financial performance, valuation, quality metrics, and technical indicators. Despite recent quarterly setbacks, the company’s long-term growth prospects and valuation appeal have improved, prompting a more balanced outlook from analysts." }, { "title": "Healthcare Global Enterprises Ltd Quality Grade Upgrade Signals Mixed Business Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-ltd-quality-grade-upgrade-signals-mixed-business-fundamentals-3827692", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_qualitydot_3827692.png", "date": "2026-02-09 08:00:18", "description": "Healthcare Global Enterprises Ltd has seen its quality rating improve from below average to average, reflecting notable shifts in its business fundamentals. While key growth metrics and operational efficiency have strengthened, concerns remain around profitability ratios and leverage levels, painting a nuanced picture for investors evaluating this hospital sector stock." }, { "title": "Healthcare Global Enterprises Ltd Falls 4.09%: Debt and Losses Cloud Weekly Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-ltd-falls-409-debt-and-losses-cloud-weekly-performance-3826114", "imagepath": "", "date": "2026-02-07 13:03:47", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Downgrade to Sell rating amid deteriorating fundamentals</p>\n <p><strong>2 Feb:</strong> Quality grade falls to below average with elevated debt metrics</p>\n <p><strong>5 Feb:</strong> Q3 FY26 results reveal loss despite revenue growth</p>\n <p><strong>6 Feb:</strong> Stock closes the week at Rs.567.55, down 4.09%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.591.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..." }, { "title": "Are Healthcare Global Enterprises Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-healthcare-global-enterprises-ltd-latest-results-good-or-bad-3824911", "imagepath": "", "date": "2026-02-06 19:28:24", "description": "Healthcare Global Enterprises Ltd's latest financial results for the quarter ended December 2025 present a complex picture. The company reported consolidated net sales of ₹633.07 crores, reflecting a year-on-year growth of 13.34%. However, this growth was accompanied by a sequential decline of 2.13% compared to the previous quarter. The operating profit, excluding other income, stood at ₹109.61 crores, with an operating margin of 17.37%, which indicates a year-on-year improvement but a sequential decline of 174 basis points.\n\nA significant concern is the consolidated net profit, which turned negative at ₹-9.43 crores, representing a dramatic year-on-year decline of 235.10%. This loss is a stark reversal from the profit of ₹16.27 crores reported in the previous quarter, raising questions about the company's operational efficiency and cost management. The profit before tax also showed a concerning shift, movi..." }, { "title": "Healthcare Global Enterprises Q3 FY26: Loss-Making Quarter Raises Concerns Despite Revenue Growth", "link": "https://www.marketsmojo.com/news/result-analysis/healthcare-global-enterprises-q3-fy26-loss-making-quarter-raises-concerns-despite-revenue-growth-3824239", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_quaterlyResult_3824239.png", "date": "2026-02-05 22:03:08", "description": "Healthcare Global Enterprises Ltd., India's leading oncology-focused hospital chain, reported a consolidated net loss of ₹9.43 crores for Q3 FY26, marking a dramatic reversal from the ₹16.27 crores profit posted in the previous quarter. This represents a sequential decline of 157.96% and a year-on-year contraction of 235.10%, sending alarm bells through investor circles. The stock, trading at ₹595.80 with a market capitalisation of ₹8,330 crores, has declined 2.11% following the results announcement, reflecting investor disappointment with the company's profitability trajectory." }, { "title": "Are Healthcare Global Enterprises Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-healthcare-global-enterprises-ltd-latest-results-good-or-bad-3822944", "imagepath": "", "date": "2026-02-05 19:31:47", "description": "Healthcare Global Enterprises Ltd's latest financial results for the quarter ended September 2025 present a mixed picture. The company reported consolidated net sales of ₹646.85 crores, reflecting a year-on-year growth of 16.86%, which is an improvement from the previous year's growth rate of 13.68%. This performance indicates a strong revenue trajectory, driven by increased patient footfall and enhanced service offerings across its network of cancer care centres.\n\nHowever, the consolidated net profit for the same period was ₹16.27 crores, which represents a decline of 9.56% compared to the previous year, contrasting sharply with the profit growth of 32.57% seen in the same quarter of the prior year. This decline raises concerns about the company's profitability despite the revenue growth.\n\nThe operating margin, excluding other income, improved to 19.11%, up from 18.51% in the previous year, indicating some..." }, { "title": "Healthcare Global Enterprises Ltd Downgraded to Sell Amid Weak Fundamentals and Elevated Debt", "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-ltd-downgraded-to-sell-amid-weak-fundamentals-and-elevated-debt-3815813", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_mojoScore_3815813.png", "date": "2026-02-02 08:44:02", "description": "Healthcare Global Enterprises Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite a respectable long-term stock return, the company’s deteriorating fundamentals and high leverage have raised concerns among analysts, prompting a cautious stance on the hospital sector player." }, { "title": "Healthcare Global Enterprises Ltd Downgraded as Quality Parameters Deteriorate", "link": "https://www.marketsmojo.com/news/stocks-in-action/healthcare-global-enterprises-ltd-downgraded-as-quality-parameters-deteriorate-3815239", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HealthcareGloba_qualitydot_3815239.png", "date": "2026-02-02 08:00:35", "description": "Healthcare Global Enterprises Ltd, a key player in the hospital sector, has seen its quality grading downgraded from average to below average, reflecting a notable deterioration in its business fundamentals. Despite impressive long-term returns, recent financial metrics and leverage ratios have raised concerns among analysts, prompting a downgrade to a Sell rating with a Mojo Score of 44.0 as of 1 February 2026." }, { "title": "Healthcare Global Enterprises Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/healthcare-global-enterprises-ltd-is-rated-hold-3809219", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/HealthcareGloba_mojoScore_3809219.png", "date": "2026-01-29 10:10:47", "description": "Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 24 November 2025. While this rating change occurred several weeks ago, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 January 2026, providing investors with an up-to-date perspective on the company’s standing." } ], "total": 224, "sid": "1002586", "stock_news_url": "https://www.marketsmojo.com/news/healthcare-global-enterprises-1002586" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "06-Feb-2026", "details": "This is to inform that the Company has updated the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2025 to incorporate certain clarifications/corrections. Accordignly the earlier Investor Presentation filed with the Stock Exchanges may be treated as withdrawn and superseded.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "06-Feb-2026", "details": "The Press Release on the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended on December 31 2025 is enclosed.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "06-Feb-2026", "details": "Please find enclosed herewith the copies of newspaper advertisement published in Business Standard (English) and Vijayawani (Kannada) on February 06 2026 with regard to approval of Unaudited Financial Results (standalone and consolidated) of the Company for the quarter and nine months ended December 31 2025 at the meeting of the Board of Directors held on February 05 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Downgrade to Sell rating amid deteriorating fundamentals

2 Feb: Quality grade falls to below average with elevated debt metrics

5 Feb: Q3 FY26 results reveal loss despite revenue growth

6 Feb: Stock closes the week at Rs.567.55, down 4.09%

Week Open

Rs.591.75

Week Close

Read full news article

Are Healthcare Global Enterprises Ltd latest results good or bad?

2026-02-06 19:28:24

Healthcare Global Enterprises Ltd's latest financial results for the quarter ended December 2025 present a complex picture. The company reported consolidated net sales of ₹633.07 crores, reflecting a year-on-year growth of 13.34%. However, this growth was accompanied by a sequential decline of 2.13% compared to the previous quarter. The operating profit, excluding other income, stood at ₹109.61 crores, with an operating margin of 17.37%, which indicates a year-on-year improvement but a sequential decline of 174 basis points. A significant concern is the consolidated net profit, which turned negative at ₹-9.43 crores, representing a dramatic year-on-year decline of 235.10%. This loss is a stark reversal from the profit of ₹16.27 crores reported in the previous quarter, raising questions about the company's operational efficiency and cost management. The profit before tax also showed a concerning shift, movi...

Read full news article

Healthcare Global Enterprises Q3 FY26: Loss-Making Quarter Raises Concerns Despite Revenue Growth

2026-02-05 22:03:08

Healthcare Global Enterprises Ltd., India's leading oncology-focused hospital chain, reported a consolidated net loss of ₹9.43 crores for Q3 FY26, marking a dramatic reversal from the ₹16.27 crores profit posted in the previous quarter. This represents a sequential decline of 157.96% and a year-on-year contraction of 235.10%, sending alarm bells through investor circles. The stock, trading at ₹595.80 with a market capitalisation of ₹8,330 crores, has declined 2.11% following the results announcement, reflecting investor disappointment with the company's profitability trajectory.

Read full news article

Are Healthcare Global Enterprises Ltd latest results good or bad?

2026-02-05 19:31:47

Healthcare Global Enterprises Ltd's latest financial results for the quarter ended September 2025 present a mixed picture. The company reported consolidated net sales of ₹646.85 crores, reflecting a year-on-year growth of 16.86%, which is an improvement from the previous year's growth rate of 13.68%. This performance indicates a strong revenue trajectory, driven by increased patient footfall and enhanced service offerings across its network of cancer care centres. However, the consolidated net profit for the same period was ₹16.27 crores, which represents a decline of 9.56% compared to the previous year, contrasting sharply with the profit growth of 32.57% seen in the same quarter of the prior year. This decline raises concerns about the company's profitability despite the revenue growth. The operating margin, excluding other income, improved to 19.11%, up from 18.51% in the previous year, indicating some...

Read full news article

Healthcare Global Enterprises Ltd Downgraded to Sell Amid Weak Fundamentals and Elevated Debt

2026-02-02 08:44:02

Healthcare Global Enterprises Ltd has been downgraded from a Hold to a Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite a respectable long-term stock return, the company’s deteriorating fundamentals and high leverage have raised concerns among analysts, prompting a cautious stance on the hospital sector player.

Read full news article

Healthcare Global Enterprises Ltd Downgraded as Quality Parameters Deteriorate

2026-02-02 08:00:35

Healthcare Global Enterprises Ltd, a key player in the hospital sector, has seen its quality grading downgraded from average to below average, reflecting a notable deterioration in its business fundamentals. Despite impressive long-term returns, recent financial metrics and leverage ratios have raised concerns among analysts, prompting a downgrade to a Sell rating with a Mojo Score of 44.0 as of 1 February 2026.

Read full news article

Healthcare Global Enterprises Ltd is Rated Hold

2026-01-29 10:10:47

Healthcare Global Enterprises Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 24 November 2025. While this rating change occurred several weeks ago, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 January 2026, providing investors with an up-to-date perspective on the company’s standing.

Read full news article